Evaluation of Total and IgA-Specific Antibody Targeting Epstein-Barr Virus Glycoprotein 350 and Nasopharyngeal Carcinoma Risk

MLA

Kelly J. Yu, et al. “Evaluation of Total and IgA-Specific Antibody Targeting Epstein-Barr Virus Glycoprotein 350 and Nasopharyngeal Carcinoma Risk.” The Journal of Infectious Diseases, vol. 218, Apr. 2018, pp. 886–91. EBSCOhost, https://doi.org/10.1093/infdis/jiy250.

APA

Kelly J. Yu, Wan-Lun Hsu, Anna E. Coghill, Hanh T. Nguyen, Jeffrey I. Cohen, Wei Bu, Yin-Chu Chien, Allan Hildesheim, & Chien-Jen Chen. (2018). Evaluation of Total and IgA-Specific Antibody Targeting Epstein-Barr Virus Glycoprotein 350 and Nasopharyngeal Carcinoma Risk. The Journal of Infectious Diseases, 218, 886–891. https://doi.org/10.1093/infdis/jiy250

Chicago

Kelly J. Yu, Wan-Lun Hsu, Anna E. Coghill, Hanh T. Nguyen, Jeffrey I. Cohen, Wei Bu, Yin-Chu Chien, Allan Hildesheim, and Chien-Jen Chen. 2018. “Evaluation of Total and IgA-Specific Antibody Targeting Epstein-Barr Virus Glycoprotein 350 and Nasopharyngeal Carcinoma Risk.” The Journal of Infectious Diseases 218 (April): 886–91. doi:10.1093/infdis/jiy250.